# Century Therapeutics

Century Therapeutics is an Asset Manager based in Philadelphia, United States.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Philadelphia, United States
- **Region:** Europe
- **Address:** Leverkusen, Philadelphia, Madison, Germany
- **Assets under management:** Undisclosed
- **Website:** centurytx.com
- **LinkedIn:** https://www.linkedin.com/company/centurytx

## Regulatory record

- **Reports private funds:** No

## About

Century Therapeutics develops allogeneic iPSC-derived NK and T cell therapies. The therapies are designed to achieve greater effectiveness, tolerability, accessibility, and affordability than existing cell therapies.

## Sectors

- Biotechnology
- Cell Therapy
- Autoimmune Diseases
- Oncology

## Offices

- Branchburg
- Boston
- Leverkusen

## Questions

### What is Century Therapeutics' core technology platform?

Century uses induced pluripotent stem cells (iPSCs) as a starting material to manufacture allogeneic NK and T cell therapies. The platform relies on a single clonal master cell bank that is gene-edited with multiple transgenes for enhanced persistence, tumor targeting, and allo-evasion. This approach aims to produce an off-the-shelf product that avoids the patient-specific manufacturing required by autologous CAR-T therapies.

### What is the current lead clinical candidate for Century Therapeutics?

The company's lead disclosed program is CNTY-101, an allogeneic, iPSC-derived NK cell therapy targeting CD19. The candidate incorporates multiple gene edits, including a CD19-targeting CAR, IL-15 pathway support, and allo-evasion strategies designed to prevent host rejection. It is being evaluated for relapsed or refractory B-cell malignancies.

## Related profiles

- [High Alpha](https://altss.com/profile/high-alpha)
- [Eliem Therapeutics](https://altss.com/profile/eliem-therapeutics)

---

Last updated: 2026-07-11T16:18:45.000Z

Canonical page: https://altss.com/profile/century-therapeutics

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology